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Background: Chemokine CX3CL1 possesses unique properties, including combined adhesive and chemotactic
functions. Human amniotic epithelial cells (HAEC) show expression of CX3CL1 receptor (CX3CR1) and produce
CX3CL1 in response to both physiologic and pathologic stimuli. Chorioamnionitis (ChA) is a common complication
of pregnancy and labour. ChA is often accompanied by local hypoxia because of the high oxygen consumption at
the site of inflammation. We examined comparatively (ChA-complicated vs. normal pregnancy) CX3CR1 expression
and the effects of hypoxia, lipopolysaccharide (LPS), and CX3CR1 blockade on CX3CL1 production in HAEC cultured
in vitro.
Methods: HAEC have been isolated using trypsinization, and cultured under normoxia (20% O2) vs. hypoxia (5%
O2). According to the experimental design, LPS (1 μg/ml) and neutralizing anti-CX3CR1 antibodies were added at
respective time points. Mean CX3CL1 concentration in the supernatant samples were determined by ELISA. Expression of
immunostained CX3CR1 was analyzed using quantitative morphometry.
Results: We have found that the mean levels of CX3CL1 and CX3CR1 expression were remarkably (p < 0.05) higher in
ChA, compared to normal pregnancy. Significantly increased expression of CX3CR1 was observed in ChA during both
normoxia and hypoxia. Hypoxia exposure produced decrease in the mean concentration of CX3CL1 in both groups,
however this reduction was stronger in normal pregnancy. In normoxia, LPS-evoked rise in the mean concentration of
CX3CL1 was higher (p < 0.05) in normal pregnancy. This response was positively correlated with CX3CR1 expression.
Blockade of CX3CR1 canceled the secretory response to LPS in all groups.
Conclusions: ChA-complicated pregnancy up-regulates CX3CR1 in HAEC cultured in vitro with simultaneous increase in
CX3CL1 production. Hypoxia-resistant production of CX3CL1 may be responsible for ChA-related complications of
pregnancy and labor.
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Chemokines comprise a heterogeneous family of low-
molecular mass cytokines (8-15 kDa) [1]. The major roles
of chemokines are to act as chemoattractants to guide the
migration of leukocytes and to modulate immune re-
sponses [2]. Members of the chemokine family are divided
into four groups based on the spacing of their first two cyst-
eine residues [3,4]. The chemokine CX3CL1 (known also
as fractalkine or neurotactin) was first described in 1997 by
Bazan et al. and Pan et al. [5,6]. Located on human
chromosome 16, CX3CL1 is the only CX3C (delta) sub-
family member, with three amino acid residues located be-
tween the first two cysteine residues in the molecular
formula. Unlike other chemokines, CX3CL1 is of non-
hemopoietic origin and shows potent chemoattractant
properties for natural killer (NK) cells, T cells and mono-
cytes, but not neutrophils [5]. CX3CL1 exists in two forms:
as a transmembrane protein with a chemokine domain
fixed to a long mucin-like stalk and as a soluble peptide
that cleaves from the cell surface [7]. It has been previ-
ously shown that the main roles of membrane-bound
CX3CL1 include promotion of leukocyte binding and ad-
hesion, as well as activation of target cells. However, the
soluble chemokine domain of human CX3CL1 is chemo-
tactic for T cells and monocytes [8]. Its dual role as an ad-
hesive particle and a chemoattractant makes CX3CL1
unique. Most stimuli that influence cell homeostasis po-
tentially induce CX3CL1 secretion [9].
CX3CL1 acts in humans via its receptor, CX3CR1 (previ-
ously named V28), which is also known as the fractalkine
receptor [10]. This receptor is a member of a large protein
family of transmembrane receptors, G protein-coupled re-
ceptors (GPCRs). Stimulation of CX3CR1 evokes activation
of both CX3CL1-dependent and integrin-dependent migra-
tion of cells with augmented adhesion as a result of syner-
gistic reactions [10,11].
It is well understood that physiological phenomena re-
lated to normal growth, development and reproduction
of living organisms are governed by a complex chemo-
kine network [12-14]. Multiple authors suggest that, to
some degree, normal pregnancy is a controlled inflam-
matory state and that many complications of pregnancy
are related to exaggerated inflammatory response (local
or systemic) [15,16]. Therefore, a successful pregnancy
depends on a balance between anti-inflammatory and
pro-inflammatory cytokines [17].
The data regarding the role of CX3CL1 in reproduction
are still accumulating [18]. Together with several other cy-
tokines (e.g., CCL7, CCL4, CCL14), CX3CL1 is involved in
the processes of implantation, invasion of the trophoblast
into the spiral uterine arteries, placental angiogenesis,
response to inflammatory and immunologic factors
within the utero-placental interface, and induction of
labor [19-21].Human amniotic epithelial cells (HAEC) are released
into amniotic fluid by various cytokines, including che-
mokines and CX3CL1. During the course of pregnancy,
the chemokine profile of HAEC may be modified by
many factors. Considering that CX3CL1 regulates accu-
mulation of lymphocytes in regions of inflammation,
the expression of this chemokine is expected to be up-
regulated by inflammatory stimuli [22,23]. However,
inflammation is often accompanied by significant local
reductions in oxygen availability [24].
Data available from both in vitro and in vivo experiments
indicate that hypoxia markedly inhibits production of
CX3CL1 [25,26]. This is perplexing because both in-
flammation and hypoxia produce an increase in the
local concentration of tumor necrosis factor alpha
(TNF-α), a well-known inducer of CX3CL1 production
and CX3CR1 expression [9,27,28].
Chorioamnionitis (ChA), also referred to as inflamma-
tion of the fetal membranes (amnion and chorion), is a
common complication of pregnancy associated with signifi-
cant maternal, perinatal and long-term adverse outcomes
[29,30]. ChA is caused by a breach in the normal defenses
of the uterine interior by bacteria, typically ascending from
lower in the vagina. ChA can cause blood infection
(bacteremia) in the mother and serious infection in the
fetus/newborn. Additionally, ChA may predispose pregnant
women to increased uterine contractility and thus a height-
ened risk of premature labor. The role of CX3CL1 in pre-
mature rupture of membranes (PROM) and preterm labor
is still under investigation [31].
The aim of this study was to examine and compare
ChA-complicated vs. normal-course pregnancy (group I
vs. group II, respectively) in respect of the influence of
different oxygen tensions (normoxia and hypoxia) on
lipopolysaccharide (LPS)-induced CX3CL1 production
in HAEC cultured in vitro.
Materials and methods
Tissue collection
This study was conducted in compliance with inter-
national and local laws of human experimentation and
was officially approved by a local ethics committee of
the Medical University of Warsaw, Poland; written con-
sents were obtained from the women for the use of their
extraplacental membranes. The study was carried out in ac-
cordance with The Code of Ethics of the World Medical
Association (Declaration of Helsinki) for experiments in-
volving humans, and the Uniform Requirements for manu-
scripts submitted to Biomedical Journals have been fulfilled.
The membranes in group I (N = 14; mean gestational age
269 ± 8 days) were collected after single term pregnancies
terminated by cesarean section due to developing symp-
toms of inflammation without the possibility of the rapid
completion of vaginal delivery in patients with rupture of
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blood tests performed during pregnancy and labor
(leukocyte count >15 × 109/L; C-reactive protein concen-
trations in three consecutive tests >10 mg/L) confirmed by
light microscopic evidence of histologic inflammation (infil-
trations of inflammatory cells) (Figure 1B,D). The mem-
branes in group II (N = 14; singleton pregnancies, mean
gestational age 272 ± 7 days) were obtained after elective
cesarean sections due to breech presentation of the fetus in
primigravida or retinal diseases with contraindications to
vaginal delivery (Figure 1A,C).
Cell culture & determination of CX3CL1 concentration
HAEC were isolated by the method of Okita et al. as
described elsewhere [32,33]. Briefly, immediately following
delivery of the afterbirth (placenta), amnion samples of 6 ×
6 cm were manually separated from the chorion, washed
with phosphate-buffered saline (PBS) and incubated for 20
min with 5% trypsin (dilution 1:250; BD Difco™) at 37˚C to
dispose of adherent cellular debris. After this stage, the
trypsin was removed, and HAEC isolated from the base-
ment membrane were subjected to another, extended en-
zymatic digestion for 90 min at 37°C with 3% trypsin. The
cells were then suspended in Ham’s F12/Dulbecco’s modi-
fied Eagle medium supplemented with 10% fetal calf serum.Figure 1 Histologic images: A – normal placental membranes, HE (Hema
perivascular inflammatory infiltrate (arrow head), HE x 100; C – normal am
infiltrate (arrow head), HE x 400; E – HEAC in culture, phase contrast x 10
transformed for morphometric purposes), x 200.HAEC were seeded at a density of 1 × 105 cells/well in 24-
well culture plate inserts (BD Falcon, NJ, USA) (Figure 1E).
Four HAEC cultures were established from each placenta,
resulting in a total of 112 cultures examined in total from
both groups (56 per group).
Isolated cells had a polygonal epithelioid appearance with
perinuclear inclusions and were almost homogenous (mini-
mum 97% of purity). The vast majority of cells were posi-
tive for specific simple epithelial cytokeratin peptide 18
(Abcam, USA) and were negative for specific macrophage/
monocyte markers: CD68 (Dako, Denmark) and HLA-DR
(Santa Cruz, USA). The cultures were kept in normoxia at
37˚C in a humidified atmosphere (relative humidity of 95%)
and reached confluence at approximately day 5 to day 6. At
this time, the supernatants were obtained for immunoenzy-
matic assay (ELISA) of the initial concentration of CX3CL1
in the cultures. The applied method for the determination
of CX3CL1 using RayBio® Human Fractalkine ELISA Kit
has a very high specificity; to the best of our knowledge,
it exceeds other available ELISA tests for detection of
CX3CL1 in cell culture media.
Subsequently, cultured HAEC in both groups were di-
vided into subgroups: normoxic (20% O2, 75% N2, 5% CO2;
groups IA and IIA, respectively) and hypoxic (5% O2, 90%
N2, 5% CO2; groups IB and IIB, respectively). The levels oftoxylin & Eosin, the routine staining) x 100; B – chorioamnionitis with
nion, HE x 400; D – chorioamnionitis with perivascular inflammatory
0; F – CX3CR1 immunostained in HAEC culture (image digitally
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and 72 h time points. The influence of lipopolysaccharide
(LPS, 1 μg/ml) on the secretory response was also exam-
ined. To evaluate the effect of CX3CR1 receptor blockade
on CX3CL1 production under hypoxia and normoxia in
both the absence and presence of LPS in the culture
medium, additional subgroups were formed. To block
CX3CR1 in HAEC cultures in vitro, rabbit anti-human
CX3CR1 "neutralizing" antibodies (dilution 1:300; TP502;
Torrey Pines Bipolabs, Inc., NJ, USA) were added to the
medium. Respective controls were established within each
of the subgroups. A general scheme of the culture develop-
ment within the groups and time frames of the research
procedures is shown in Figure 2.
Immunohistochemistry and mean expression of CX3CR1
Both the initial (Ei; normoxia; approximately day 5 to
day 6 of culture) and final (Ef; 72 hours after subsequent
continuation of the cell cultures under hypoxia or nor-
moxia) expression levels of fractalkine receptor CX3CR1
were compared between the study groups. To perform
this task, some of the cultures within the study groups
(N = 24 per group) were formalin fixed and paraffin em-
bedded at the above-mentioned time points. CX3CR1
was visualized using a standard immunohistochemical
procedure. Rabbit polyclonal antibody IgG to CX3CR1
(ab8020; Abcam Inc., USA; concentration of 10 μg/ml)
was used as the primary antibody, and goat anti-rabbit IgGIIA.                
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Figure 2 General scheme of the cultures developed within the stud
0,1,2,3 – measurements of CX3CL1 concentration in the culture me
(the initial and final, respectively).was used as the biotinylated secondary antibody (ab64256;
Abcam; 0.5% v/v). The visualization of primary anti-
receptor antibodies was conducted using a StreptABCom-
plex/HRP Duet (Dako Cytomation, Glostrup, Denmark)
following the procedure recommended by the manufac-
turer, with 3,3’-diaminobenzidine serving as a chromogen.
Negative controls for the immunostaining were set up by
replacement of the polyclonal primary antibody with
normal rabbit preimmune IgG diluted with phosphate
buffered saline, containing 3% bovine serum albumin at
the same protein concentration as that used for the pri-
mary antibody.
Quantitative immunohistochemistry using morpho-
metric software (Quantimet 500C+, Leica, UK) was ap-
plied for CX3CR1 receptor identification in paraffin 5
μm sections of the HAEC cultures under light micros-
copy (Figure 1F). All morphometric procedures were
carried out twice by two independent observers, and the
average results were recorded. The intensity of immuno-
staining was evaluated using mean color saturation pa-
rameters and thresholds in grey-level histograms.
Expression of CX3CR1 corresponded to the total im-
munostained calibrated area of examined sections, where
color saturation comprises segmentation-separation criteria
for objects. Each single analyzed image area was 138 692
μm2 (magnification × 200). In each group, 72 visual fields
were analyzed (36 visual fields per each time point marked
Ei and Ef as previously stated). To assure optimal accuracy                        
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or monitored: illumination, power supply, warming up,
shading correction, averaging of image intake, hue, lumi-
nance, relation of illumination to quantification of area
percentage of positively staining structures. More detailed
descriptions of these morphometric procedures have been
given elsewhere [34,35]. Morphometric results with 90%
confidence intervals were reported as the mean percentage
values ± SEM.
Determination of TNF-α concentration
The measurement of the TNF-α levels in the culture su-
pernatants was performed for all studied HAEC groups by
ELISA. A commercially available kit was used (ELH-
TNFalpha-001, RayBio Human TNF-alpha ELISA Kit,
RayBiotech, Inc., USA) according to the manufacturer’s
instructions. The minimum detectable dose of TNF-α was
established as less than 30 pg/ml.
Statistical analysis
Mann-Whitney’s U-test was applied. The results are
expressed as the means ± SEM or the mean percentage
values ± SEM. Differences between groups I and II (ChA-
complicated vs. normal-course pregnancy, respectively)
were deemed statistically significant if p < 0.05.
Results
CX3CL1 concentration
Chemokine CX3CL1 was present in of the culture media of
all collected specimens. The immunoenzymatic assay pro-
cedure (ELISA) used in this study revealed significant
(p < 0.05) differences in the mean CX3CL1 concentration
between the two main groups as well as between the sub-
groups, including altered secretory responses of HAEC to
LPS challenge (see Figure 3A and B). Immediately after
in vitro establishment of the HAEC cultures (5-6 days fol-
lowing enzymatic digestion of the amnion samples), the
mean levels of CX3CL1 were significantly (p < 0.05) higher
in ChA compared to normal pregnancy (controls) speci-
mens and amounted to 38.75 ± 7.48 and 39.99 ± 7.11 vs.
12.31 ± 3.28 and 13.49 ± 2.65 (μg/ml; subgroups IA, IB vs.
IIA, IIB, respectively).
In normoxia, these initial differences in CX3CL1 con-
centration were observed during the next 3 consecutive
assays: after 24, 48, and 72 hours (Figure 3A).
Hypoxia exposure for 24 hours resulted in a decrease in
the mean concentration of CX3CL1 in both groups. How-
ever, this reduction was stronger in the control group
(normal pregnancy), amounting to a 63% vs. 39% drop in
the CX3CL1 concentration measured in ChA (Figure 3B).
In repeated measurements performed every 24 hours
(48 h and 72 h after establishment of the cultures, re-
spectively), these significant changes in CX3CL1 levels
in culture media persisted almost unchanged.Supplementation of the culture media with LPS resulted
in an increased synthesis of CX3CL1 in all studied sub-
groups, as measured at the 48 h and 72 h time points. The
characteristics of this secretory response to LPS have been
shown to have strong linkage to the oxygen availability.
In normoxia, LPS-evoked rise in the mean concentra-
tion of CX3CL1 was significantly (p < 0.05) higher in the
control group (normal pregnancy) compared to the ChA
group (2.2-fold vs. 4.3-fold increase, respectively; Figure 3A).
This evolving pattern of secretory response to LPS was
observed in the control group specimens during HAEC
culture under low oxygen tension (Figure 3B). The mean
increase in CX3CL1 concentration was reduced almost 2-
fold compared to normoxia (2.2-fold vs. 4.3-fold, control
group under hypoxia and normoxia, respectively; p < 0.05),
while relative magnitude of the mean increase in CX3CL1
remained unchanged in ChA (2.2-fold vs. 2.2-fold, ChA
under hypoxia and normoxia, respectively).
Blockade of the CX3CL1-CX3CR1 interaction through
administration of “neutralizing” antibodies (rabbit anti-
human CX3CR1) resulted in complete inhibition of the
secretory response to LPS in all studied groups/subgroups.
The differences in the mean CX3CL1 concentrations be-
tween LPS-free cultures and “LPS + anti-CX3CR1” cultures
were not statistically significant (Figure 3A,B).
Expression of CX3CR1
The mean percentage values of the initial (Ei) and the
final (Ef ) CX3CR1 receptor expressions were signifi-
cantly (p < 0.05) higher in ChA under both normoxic
and hypoxic conditions, compared to the controls (nor-
mal pregnancy) (Figure 4A,B).
Administration of LPS in normoxia produced signifi-
cant (p < 0.05) differences in the percentage proportions
of CX3CR1 expression between the ChA group and the
controls. The mean expression of CX3CR1 amounted
to 163.5 ± 26.1 and 250.8 ± 31.3% ± SEM (ChA + LPS vs.
LPS-free ChA, respectively) of the values in the control
group (taken as 100%) (Figure 4A).
Under hypoxia, the mean expression of CX3CR1 follow-
ing LPS administration in ChA remained approximately
proportionally unchanged compared with the percentage
values obtained from the LPS-free ChA group (274.8 ± 32.3
and 294.8 ± 28.2% ± SEM, respectively) vs. the mean
CX3CR1 expression in the control group taken as
100% (p > 0.05) (see Figure 4B). In other words, the
presence of LPS in hypoxic HAEC cultures did not sig-
nificantly change the differences in CX3CR1 expres-
sion observed between the study groups.
Normoxia vs. hypoxia
Summarizing the data about CX3CL1 concentration and
CX3CR1 expression obtained in both groups, we observed
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Figure 3 Mean concentration of CX3CL1 in the culture media in normoxic (A) and hypoxic (B) cultures of HAEC: chorioamnionitis (ChA)
versus normal pregnancy (Control). Symbols ♥, ♦, ♣, ♠ indicate p < 0.05.
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tion was significantly increased in ChA, compared to the
controls (see Figure 3A).
Hypoxia exposure produced significant decrease in
CX3CL1 concentration in both goups. The percent-
age value of this decrease was higher in the control
group (normal pregnancy) (see Figure 3B).
The observed secretory response to LPS have also
been shown to be oxygen dependent. In normoxia,
the mean percentage increase in the mean CX3CL1
concentration was significantly higher in the normal
pregnancy compared to the ChA (Figure 3A), while
hypoxic conditions produced a two-fold reduction ofthis secretory response in group II (normal preg-
nancy) with almost not affected relative magnitude
of the mean increase in CX3CL1 in ChA (group I)
(Figure 3B).
The mean percentage values of CX3CR1 receptor
expressions were significantly higher in ChA, regard-
less of whether HAEC were grown in normoxia or
hypoxia (see Figure 4). Adminitration of LPS in nor-
moxia produced significant reduction in the mean
percentage CX3CR1 expression in ChA (Figure 4A),
while under hypoxic conditions the influence of
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Figure 4 Mean initial (Ei) and final (Ef) expressions of CX3CR1 in HAEC cultured in vitro in normoxia (A) and hypoxia (B): chorioamnionitis
(ChA) versus normal pregnancy. Mean values for normal pregnancy (0.077 ± 0.0031 and 0.043 ± 0.0024 for the subgroup IIA, and 0.029 ± 0.0018 and
0.019 ± 0.0013 for the subgroup IIB; abstract numbers ± SEM with or without LPS, respectively) were taken as 100%. * p < 0.05.
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We found that the TNF-α concentration in the culture
supernatants was below the limits of detection of the
ELISA kit used in our experimental procedure and was
not affected by hypoxia and/or administration of LPS
(data not shown).
Discussion
Humoral regulation of the compensatory-adaptive cap-
abilities of the utero-feto-placental unit to meet the
changing conditions related to the advancement ofnormal or complicated pregnancy and the onset of labor
is not clearly understood [36,37]. The effects of hor-
mones and autacoids are studied using both in vivo
and in vitro models, including isolated HAEC cultures
[38,39]. The main reproductive events, including ovu-
lation, implantation and parturition, are all related to
inflammatory-like responses [40,41]. In contrast, patho-
logically augmented inflammatory background (systemic or
localized) has been reported in patients with recurrent
pregnancy loss or habitual abortion, preterm labor and pre-
term rupture of the membranes (PROM), as well as
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sion (preeclampsia, eclampsia) [42-45]. The role of
HAEC in this inflammatory response modulation and
possible interactions with the intrauterine cytokine
network during pregnancy remain under investigation
[46,47]. To the best of our knowledge, this is the first
paper to report the importance of CX3CR1 expression
and its functional status in the maintenance of CX3CL1
production by HAEC under hypoxic conditions.
It is crucial to note that similar to all experimental
in vitro models, our approach has limitations. Compared
to in vivo conditions, isolated HAEC are separated from
the influence of natural environmental characteristics,
including tight interaction of cytokines that form a cyto-
kine network [12,48]. The increased initial concentration
of CX3CL1 in HAEC culture media obtained after ChA-
complicated pregnancy seems to reflect the previous
stimulatory influence of infective and inflammatory fac-
tors on the production and release of this chemokine
[31]. It is likely that infection-induced production of in-
flammatory cytokines, such as TNF-α, IL-1, and IFN-γ,
may stimulate CX3CR1 production in HAEC [49,50].
Induction of members of the CX3C chemokine class,
such as CX3CL1 in ChA, was relatively stable in nor-
moxia, as the differences between the groups (ChA vs.
normal pregnancy) persisted approximately unchanged
for the subsequent 3 days. The differences in CX3CL1
concentration between the groups observed under hypoxic
conditions may suggest that specific “preconditioning” in
the inflammatory environment in vivo was related to the
acquired resistance of ChA cells to decreased oxygenation
in culture. It is well documented that infection-
induced inflammation may lead to local and systemic
ischemia as a defense mechanism against pathogens
[51,52]. Both inflammation and hypoxia may trigger
TNF-α release in vivo, which has been considered a
potent up-regulator of the CX3CL1/CX3CR1 signaling
pathway [53,54]. Thus, even if CX3CL1/CX3CR1 genes
are under negative regulation (suppression) by hyp-
oxia, CX3CL1 persisted at significantly higher levels in
the culture supernatant in group I compared to HAEC
derived from a normal pregnancy (group II). Higher
levels of CX3CL1 were accompanied by an approxi-
mately 2.5-fold to nearly 3-fold increase in expression
of CX3CR1 in the ChA group (normoxia and hypoxia,
respectively; Figure 4).
Although the measured CX3CL1 levels were higher in
ChA, administration of LPS in normoxic environments
revealed a significantly higher potential for CX3CL1 pro-
duction within normal HAEC (control group), where the
relative increase in CX3CL1 concentration was approxi-
mately 2-fold higher when compared to ChA-derived
cell culture (group I; Figure 3A). Interestingly, over a
similar time period, the percentage differences betweenthe groups (ChA vs. control) in the mean CX3CR1 expres-
sion were smallest, suggesting a significant up-regulation of
CX3CR1 in the control group (normal HAEC; Figure 4A).
In hypoxic environments, the potential of normal HAEC
for CX3CL1 production disappeared, with an accompany-
ing return of the percentage differences in the mean
CX3CR1 expression to the values previously observed
without LPS (Figure 4B). The effect of neutralizing
antibodies on CX3CL1 production showed a superior
importance of CX3CR1 functional status over CX3CR1
expression both in normoxic and hypoxic environ-
ments. Accordingly, it is indicated that co-expression of
CX3CL1 and CX3CR1 in HAEC leads to an autocrine
effect of CX3CL1-induced CX3CL1 production. This
mechanism of autoregulation via CX3CR1, mediated by
heterodimeric G-proteins, phosphoinositide (PI) 3-kinase,
phosphoinositide-dependent kinase-1 (PDK1), serine/threo-
nine protein kinase (Akt), IқB kinase (IKK) and nuclear
factor қB (NF-қB) has been proposed for other cell
types [55-57].
Considering that TNF-α in all culture supernatants
demonstrated no measurable activity (concentrations
below the detectable limit), both LPS-induced CX3CL1
production and augmented CX3CR1 expression seem to
occur in a TNF-α-independent manner. Involvement of
interleukins and interferons other than TNF-α in LPS-
mediated signaling pathways in HAEC cultured in vitro
is expected [23,58]. However, in our study, we did not
measure the levels of these cytokines in culture media.
More precise disclosure of the observed positive cor-
relation between CX3CL1 levels and CX3CR1 expression
is still needed. It is expected that CX3CR1 polymor-
phisms are of biological significance. Substitution of
valine by isoleucine (V249I) and threonine by methio-
nine (T280M) in the coding region of CX3CR1 gene
has been previously reported [59]. The presence of
these two single-nucleotide polymorphisms and the
two consequentially modified alleles may produce op-
posite effects on cell adhesion. Studies using endothe-
lial cells revealed that the 280M allele decreased cell
adhesion, whereas the 249I allele was associated with
augmented or nearly unchanged cell adhesion [60,61].
Conclusions
In the present study, we demonstrated that ChA during
pregnancy up-regulates CX3CR1 expression on HAEC
in vitro with simultaneous increase in CX3CL1 produc-
tion. This response persists in HAEC culture both in
normoxia and hypoxia and may be augmented by LPS
acting through one or more TNF-α-independent mecha-
nisms. Further research may be helpful in translating the
in vitro results into in vivo applications, including the
possibility of application into clinical obstetric practical
treatment with CX3CR1 antagonists in ChA cases.
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